Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims


     Quick Explanation



    Marilee Benore is a productive, education-focused biochemist at primarily undergraduate institutions whose 36-paper, h-index≈5–7, ~163–208-citation record blends modest primary research on riboflavin-binding protein with extensive curriculum scholarship; her recent chimeric riboflavin-biotin tag work is methodologically sound but preliminary (KD 1.29–3.00 μM) .


     Long Explanation



    Career Profile and Citation Footprint

    Marilee A. Benore (also indexed as Marilee Benore-Parsons) has a split bibliographic identity: OpenAlex records two profiles, one with 17 works / 208 citations / h-index 7 and one ORCID-verified profile with 45 works / 194 citations / h-index 5 . Her most-cited work is foundational egg-yolk biochemistry: dephosphorylation of chicken riboflavin-binding protein and phosvitin decreases oocyte uptake (66 citations, J. Biol. Chem., 1982) , followed by a trypsin-proteolysis phosphorylation study (54 citations) . The remainder of her output is dominated by biochemistry education scholarship (curriculum skills matrices, online-course practices during COVID, foundational-concept assessments) .

    Interpretation note: her research impact is concentrated in early RBP work; education papers are cited moderately; current output is heavily conference abstracts, consistent with a PUI (primarily undergraduate institution) career where teaching outweighs research throughput.

    Primary Research Strength: The Riboflavin-Biotin Tag Study (2026)

    Her most recent full study characterizes a riboflavin analogue tethered to biotin (C6-Rf-biotin-tag) for potential flavin-status diagnostics. PWR spectroscopy gave KD of 1.29 ± 0.277 μM for apoRBP and 3.00 ± 0.459 μM for streptavidin; fluorescence quenching and HABA displacement support binding . Strengths: multiple orthogonal methods (UV/Vis, fluorescence, PWR, HABA competition), proper controls (DMSO, parallel Rf), transparent reporting of the negative result on simultaneous binding, and no external funding/declared conflicts — although a US patent application (PCT/US25/41035) is disclosed, a potential commercialization incentive worth weighing . Weaknesses: no avidin KD, no stated PWR replicate counts, no error statistics on fluorescence/HABA assays, and the claimed bifunctional diagnostic utility remains unproven.

    Overall Assessment

    Benore's scientific strength lies in consistent, careful in vitro protein biochemistry with a 40-year thread on riboflavin-binding protein — from phosphorylation and transport (1982) to copper-binding site characterization by EPR/XAS (2008) — plus substantial education leadership. Her metrics are modest (h-index 5–7) but appropriate for a PUI scientist whose lab trains undergraduates. Key blindspots: recent work lacks replicate reporting and quantitative validation; the diagnostic application is speculative. Confidence in this review is moderate — limited post-2008 publication data and split author identities make citation attribution uncertain.



    Feedback:    

    Updated: October 13, 2026

     BGPT Author Review



    Scientific Quality

    50%

    Modest but genuine research record: one JBC classic (66 cites), solid spectroscopic biochemistry (EPR/XAS copper work), 40-year RBP thread. Weaknesses: low h-index (5-7), recent work under-quantified (no replicates, no avidin KD), diagnostic claims ahead of evidence, heavy reliance on conference abstracts. Appropriate rigor for a PUI context but not world-class.



    Communication Quality

    70%

    Clear structured reporting with explicit limitations and negative results disclosed honestly; education writing is accessible and widely reused. Deductions for incomplete statistical reporting (no PWR replicate details) and some claims (diagnostic potential) not fully supported by the data presented.



    Author Novelty

    60%

    The chimeric riboflavin-biotin tag for flavin-status detection is a genuinely new chemical construct with a patent filed; the RBP copper-binding work was a first-in-field characterization. However, much of her output is educational/conference material with limited conceptual novelty.



    Scientific Rigor

    60%

    Multiple orthogonal methods (UV/Vis, fluorescence, PWR, HABA), proper controls, transparent negative result on simultaneous binding, funding/disclosure transparency. But missing: replicate counts for PWR, error statistics for fluorescence/HABA, no direct avidin KD, and sample sizes unreported — all reduce reproducibility confidence.

     Hypothesis Graveyard



    C6-Rf-biotin-tag could substitute for riboflavin in vivo flavin assays: refuted by the study itself — micromolar KD (1.29 μM) is far weaker than native ligand affinity, limiting diagnostic sensitivity.


    Simultaneous RBP-avidin binding failed due to tag destruction: unsupported; author showed fluorescence interference from HABA-avidin, a measurement artifact, not tag failure.

     Science Art


    Author Review: Marilee Benore Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT